Oncosem Announces 1200% Bonus Share Issue: A Major Structural Shift

Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.Ş. has announced a record-breaking 1200% bonus share issue, to be funded entirely from internal resources. This strategic move is set to significantly strengthen the company's financial structure while distributing additional shares to existing shareholders without any cash demand.

Profound Transformation in Capital Structure

The company's current issued capital will be substantially increased following this decision. The details of this capital hike are as follows:

■Current issued capital: TRY 23.85 million

■Amount to be covered from internal resources: TRY 286.2 million

■New total issued capital: TRY 310.05 million

This capital increase will be sourced from the company's retained earnings, inflation adjustment differences, and share premium accounts. This indicates that the company possesses robust internal resources and is utilizing them to fortify its capital structure.

Shareholder Impact and Regulatory Approval Process

The bonus share issue will provide a direct benefit to existing shareholders, who will receive new shares proportionate to their current holdings:

■Existing shareholders will be granted bonus shares in proportion to their current shareholding.

■Class A shareholders will receive Class A shares, and Class B shareholders will receive Class B shares.

Completion of this process is contingent upon necessary applications to relevant authorities, primarily the Capital Markets Board (SPK). Furthermore, Oncosem's registered capital ceiling of TRY 99 million can be exceeded for this transaction on a one-off basis, thanks to a special exemption granted under SPK regulations.

Analysis by Dr. Aslıhan Demir: Oncosem's decision to proceed with a remarkably high 1200% bonus share issue reflects the company's strong accumulation of internal resources and its strategy to grow its balance sheet in real terms within an inflationary environment. The utilization of inflation adjustment differences as a source particularly highlights the impact of high inflation in the Turkish economy on corporate balance sheets and companies' efforts to adapt. Such a step can boost investor confidence in the company's financial strength and future growth potential. From a macroeconomic perspective, these types of internally funded capital increases can contribute to the deepening of capital markets without creating a cash demand in the market, potentially having a positive effect on company valuations.